UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Sixth Street Specialty
TSLX
$1.78B
| $9.35M | ﹤0.01% |
438,758
+38,027
| +9% | +$789K |
|
3127
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
| $9.33M | ﹤0.01% |
463,949
-11,526
| -2% | -$229K |
|
3128
Innospec
IOSP
$2.25B
| $9.32M | ﹤0.01% |
84,672
+68,129
| +412% | +$7.8M |
|
3129
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
| $9.3M | ﹤0.01% |
263,743
-10,416
| -4% | -$376K |
|
3130
Alpha Teknova
TKNO
$350M
| $9.3M | ﹤0.01% |
1,113,196
+1,112,745
| +246,728% | +$7.75M |
|
3131
Simplify Enhanced Income ETF
HIGH
$70.4M
| $9.29M | ﹤0.01% |
403,712
-347,085
| -46% | -$8.15M |
|
3132
Boot Barn
BOOT
$4.97B
| $9.29M | ﹤0.01% |
61,187
+26,762
| +78% | +$3.95M |
|
3133
Teladoc Health
TDOC
$1.21B
| $9.28M | ﹤0.01% |
1,020,759
-36,151
| -3% | -$349K |
|
3134
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$619M
| $9.27M | ﹤0.01% |
273,249
+14,961
| +6% | +$517K |
|
|
MREO
3135
Mereo BioPharma
MREO
$48.8M
| $9.27M | ﹤0.01% |
+2,648,140
| New | +$10.4M |
|
3136
Invesco S&P International Developed Low Volatility ETF
IDLV
$346M
| $9.27M | ﹤0.01% |
333,073
+4,218
| +1% | +$122K |
|
3137
Prudential
PUK
$34.7B
| $9.27M | ﹤0.01% |
581,342
+338,610
| +139% | +$5.67M |
|
3138
Portland General Electric
POR
$5.71B
| $9.26M | ﹤0.01% |
212,238
-151,291
| -42% | -$7.04M |
|
3139
American States Water
AWR
$3.36B
| $9.26M | ﹤0.01% |
119,104
+28,483
| +31% | +$2.37M |
|
3140
Praxis Precision Medicines
PRAX
$10.3B
| $9.26M | ﹤0.01% |
120,267
+90,717
| +307% | +$6.56M |
|
3141
Invesco Financial Preferred ETF
PGF
$672M
| $9.25M | ﹤0.01% |
635,889
+70,085
| +12% | +$1.07M |
|
3142
PUT
Amcor
AMCR
$21.8B
| $9.25M | ﹤0.01% |
196,600
-8,180
| -4% | -$427K |
|
3143
iShares US Infrastructure ETF
IFRA
$4.56B
| $9.25M | ﹤0.01% |
199,787
+8,019
| +4% | +$388K |
|
3144
Central Garden & Pet Co Class A
CENTA
$2.54B
| $9.23M | ﹤0.01% |
279,369
+121,494
| +77% | +$3.87M |
|
3145
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.76B
| $9.23M | ﹤0.01% |
188,738
-2,693
| -1% | -$138K |
|
|
CVSA
3146
Covista Inc
CVSA
$4.23B
| $9.23M | ﹤0.01% |
101,610
+60,715
| +148% | +$5.08M |
|
3147
Brunswick
BC
$5.28B
| $9.23M | ﹤0.01% |
142,717
+105,860
| +287% | +$8.3M |
|
3148
Nelnet
NNI
$4.85B
| $9.22M | ﹤0.01% |
86,297
+67,610
| +362% | +$7.47M |
|
3149
PUT
Manulife Financial
MFC
$74.1B
| $9.21M | ﹤0.01% |
300,000
| – | – |
|
3150
Alkermes
ALKS
$8.11B
| $9.2M | ﹤0.01% |
319,925
-187,494
| -37% | -$5.39M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.